Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Regulation and use of the extracellular matrix by Trypanosoma cruzi during early infection.

Nde PN, Lima MF, Johnson CA, Pratap S, Villalta F.

Front Immunol. 2012 Nov 6;3:337. doi: 10.3389/fimmu.2012.00337. eCollection 2012.

2.

REGULATION of the EXTRACELLULAR MATRIX INTERACTOME by Trypanosoma cruzi.

Cardenas TC, Johnson CA, Pratap S, Nde PN, Furtak V, Kleshchenko YY, Lima MF, Villalta F.

Open Parasitol J. 2010;4:72-76.

3.

Gene network analysis during early infection of human coronary artery smooth muscle cells by Trypanosoma cruzi and Its gp83 ligand.

Nde PN, Johnson CA, Pratap S, Cardenas TC, Kleshchenko YY, Furtak VA, Simmons KJ, Lima MF, Villalta F.

Chem Biodivers. 2010 May;7(5):1051-64. doi: 10.1002/cbdv.200900320.

4.

Thrombospondin-1 interacts with Trypanosoma cruzi surface calreticulin to enhance cellular infection.

Johnson CA, Kleshchenko YY, Ikejiani AO, Udoko AN, Cardenas TC, Pratap S, Duquette MA, Lima MF, Lawler J, Villalta F, Nde PN.

PLoS One. 2012;7(7):e40614. doi: 10.1371/journal.pone.0040614. Epub 2012 Jul 11.

5.

Immunization with Hexon modified adenoviral vectors integrated with gp83 epitope provides protection against Trypanosoma cruzi infection.

Farrow AL, Rachakonda G, Gu L, Krendelchtchikova V, Nde PN, Pratap S, Lima MF, Villalta F, Matthews QL.

PLoS Negl Trop Dis. 2014 Aug 21;8(8):e3089. doi: 10.1371/journal.pntd.0003089. eCollection 2014 Aug.

6.

Silencing of the laminin gamma-1 gene blocks Trypanosoma cruzi infection.

Nde PN, Simmons KJ, Kleshchenko YY, Pratap S, Lima MF, Villalta F.

Infect Immun. 2006 Mar;74(3):1643-8.

7.

Exogenous Calreticulin, incorporated onto non-infective Trypanosoma cruzi epimastigotes, promotes their internalization into mammal host cells.

Sosoniuk-Roche E, Vallejos G, Aguilar-Guzmán L, Pizarro-Bäuerle J, Weinberger K, Rosas C, Valck C, Michalak M, Ferreira A.

Immunobiology. 2017 Mar;222(3):529-535. doi: 10.1016/j.imbio.2016.10.020. Epub 2016 Oct 29.

PMID:
27839837
8.
9.

Reevaluating the Trypanosoma cruzi proteomic map: The shotgun description of bloodstream trypomastigotes.

Brunoro GV, Caminha MA, Ferreira AT, Leprevost Fda V, Carvalho PC, Perales J, Valente RH, Menna-Barreto RF.

J Proteomics. 2015 Feb 6;115:58-65. doi: 10.1016/j.jprot.2014.12.003. Epub 2014 Dec 20.

PMID:
25534883
10.

Is the Antitumor Property of Trypanosoma cruzi Infection Mediated by Its Calreticulin?

Ramírez-Toloza G, Abello P, Ferreira A.

Front Immunol. 2016 Jul 11;7:268. doi: 10.3389/fimmu.2016.00268. eCollection 2016. Review.

11.

Trypanosoma cruzi calreticulin inhibits the complement lectin pathway activation by direct interaction with L-Ficolin.

Sosoniuk E, Vallejos G, Kenawy H, Gaboriaud C, Thielens N, Fujita T, Schwaeble W, Ferreira A, Valck C.

Mol Immunol. 2014 Jul;60(1):80-5. doi: 10.1016/j.molimm.2014.03.014. Epub 2014 Apr 24.

PMID:
24769495
12.

Molecular characterization and interactome analysis of Trypanosoma cruzi tryparedoxin II.

Arias DG, Piñeyro MD, Iglesias AA, Guerrero SA, Robello C.

J Proteomics. 2015 Apr 29;120:95-104. doi: 10.1016/j.jprot.2015.03.001. Epub 2015 Mar 10.

PMID:
25765699
13.

Evasion of the Immune Response by Trypanosoma cruzi during Acute Infection.

Cardoso MS, Reis-Cunha JL, Bartholomeu DC.

Front Immunol. 2016 Jan 18;6:659. doi: 10.3389/fimmu.2015.00659. eCollection 2015. Review.

14.
15.

A soluble factor from Trypanosoma cruzi inhibits transforming growth factor-ß-induced MAP kinase activation and gene expression in dermal fibroblasts.

Mott GA, Costales JA, Burleigh BA.

PLoS One. 2011;6(9):e23482. doi: 10.1371/journal.pone.0023482. Epub 2011 Sep 8.

16.

Molecular analysis of early host cell infection by Trypanosoma cruzi.

Villalta F, Madison MN, Kleshchenko YY, Nde PN, Lima MF.

Front Biosci. 2008 May 1;13:3714-34. Review.

17.
18.

Adhesion of Trypanosoma cruzi trypomastigotes to fibronectin or laminin modifies tubulin and paraflagellar rod protein phosphorylation.

Mattos EC, Schumacher RI, Colli W, Alves MJ.

PLoS One. 2012;7(10):e46767. doi: 10.1371/journal.pone.0046767. Epub 2012 Oct 4.

19.

Comprehensive glycoprofiling of the epimastigote and trypomastigote stages of Trypanosoma cruzi.

Alves MJ, Kawahara R, Viner R, Colli W, Mattos EC, Thaysen-Andersen M, Larsen MR, Palmisano G.

J Proteomics. 2017 Jan 16;151:182-192. doi: 10.1016/j.jprot.2016.05.034. Epub 2016 Jun 16.

PMID:
27318177
20.

A ligand that Trypanosoma cruzi uses to bind to mammalian cells to initiate infection.

Villalta F, Smith CM, Ruiz-Ruano A, Lima MF.

FEBS Lett. 2001 Sep 21;505(3):383-8.

Supplemental Content

Support Center